Overview

• Immediate action is needed to address an unprecedented multi-year upsurge in cholera cases, with over 700,000 cases reported in 2023.
• The global cholera vaccine stockpile is under unprecedented pressure due to severe shortages, with demand far exceeding supply.
• Efforts to increase access to clean water, sanitation, and hygiene are essential to combat the spread of cholera.
• Only one manufacturer, EuBiologics, currently produces the cholera vaccine, with production unable to meet the soaring demand.
• Governments, donors, and vaccine manufacturers are urged to fast-track additional production and invest in preventive measures to control the cholera outbreak.